What are burr cells?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Burr Cells (Echinocytes): Definition and Clinical Significance

Burr cells (echinocytes) are abnormally shaped red blood cells with multiple, evenly spaced projections on their surface, giving them a crenated appearance that can be identified on peripheral blood smear examination. 1

Morphological Characteristics

  • Burr cells have multiple, evenly spaced projections on their surface, creating a characteristic crenated appearance that distinguishes them from normal erythrocytes 1
  • These cells maintain their overall round shape but display uniform spiculations around their periphery, unlike other abnormal red cell forms 2
  • They can be readily identified during routine peripheral blood smear examination as part of a complete blood count workup 1

Pathophysiological Mechanisms

  • Formation of burr cells primarily results from alterations in red blood cell membrane composition, particularly due to:
    • Changes in phospholipid membrane asymmetry due to oxidative stress 2
    • Alterations in phosphatidylserine and phosphatidylinositol concentrations in the cell membrane 3
    • Accumulation of uremic toxins affecting membrane structure 2
    • Effects of hyperbilirubinemia triggering eryptosis (programmed death of erythrocytes) 2

Clinical Significance and Disease Associations

  • Burr cells are a significant independent predictor of 30-day mortality, associated with a 3-fold increase in risk of death when present on admission 4
  • The presence of burr cells is strongly associated with:
    • Liver disease and hepatic failure, where bile acids and bilirubin directly affect red cell membrane structure 2
    • Chronic kidney disease and uremia, where uremic toxins stimulate eryptosis 2
    • Alcoholic liver disease, where both direct alcohol effects and progressive hepatic injury alter membrane lipid composition 3
    • Microangiopathic hemolytic anemia, where they serve as a diagnostic indicator 1

Laboratory Evaluation

  • When burr cells are identified, the following investigations should be performed:
    • Complete blood count with peripheral smear review to confirm burr cell presence and quantify their percentage 1
    • Hemolysis workup including LDH, haptoglobin, and indirect bilirubin 1
    • Liver function tests to assess for hepatic dysfunction 2
    • Renal function tests to evaluate for uremia 2

Management Implications

  • The presence of burr cells should prompt investigation of underlying conditions, particularly liver and kidney dysfunction 2
  • Treatment should focus on addressing the underlying cause:
    • In alcoholic liver disease, cessation of alcohol intake may normalize hematological parameters, though burr cells may persist 3
    • In uremia, optimization of dialysis may reduce uremic toxins and associated burr cell formation 2
    • In cases associated with parenteral nutrition, particularly fish oil supplementation, discontinuation of the offending agent may resolve the anemia 5

Prognostic Value

  • The presence of burr cells on admission is associated with a mortality rate of approximately 27.3%, particularly in patients with renal or liver failure 4
  • Regular monitoring of complete blood count and peripheral smear is recommended until resolution of the underlying condition 1
  • Burr cells should be recognized as a marker of severe underlying disease that requires prompt evaluation and management 1

References

Guideline

Burr Cells: Clinical Implications and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Causes of Burr Cells (Echinocytes) in Red Blood Cells

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Parenteral fish oil-associated burr cell anemia.

The Journal of pediatrics, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.